🇺🇸 FDA
Pipeline program

Sativex

GWCP0605

Phase 1 small_molecule completed

Quick answer

Sativex for Evaluation of Abuse Potential of Sativex is a Phase 1 program (small_molecule) at Jazz Pharmaceuticals plc with 1 ClinicalTrials.gov record(s).

Program details

Company
Jazz Pharmaceuticals plc
Indication
Evaluation of Abuse Potential of Sativex
Phase
Phase 1
Modality
small_molecule
Status
completed

Clinical trials